TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Link-Asia International Medtech Group Ltd. ( (HK:1143) ) has provided an update.
Link-Asia International Medtech Group Ltd. has announced a proposed refreshment of its Scheme Mandate Limit under the 2023 Share Option Scheme. This move is intended to provide the company with greater flexibility to motivate and reward participants for their contributions to the company. The refreshment is subject to shareholder approval at the upcoming EGM and would increase the maximum number of shares that can be issued under the scheme to 10% of the issued shares as of the EGM date. The company emphasizes that this refreshment is in the best interests of both the company and its shareholders.
The most recent analyst rating on (HK:1143) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Link-Asia International Medtech Group Ltd. stock, see the HK:1143 Stock Forecast page.
More about Link-Asia International Medtech Group Ltd.
Average Trading Volume: 1,757,216
Technical Sentiment Signal: Sell
Current Market Cap: HK$93.08M
Find detailed analytics on 1143 stock on TipRanks’ Stock Analysis page.